Retrospective Analysis of 2nd-line Nab-Paclitaxel + Gemcitabine After 1st-line FOLFIRINOX in Pancreatic Cancer

Conditions:   Pancreatic Cancer;   Metastatic Pancreatic Cancer Intervention:   Drug: nab paclitaxel plus gemcitabine Sponsors:   Asan Medical Center;   Bundang CHA Hospital;   Ulsan University Hospital Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials